CALLIDITAS THERAPEUTICS AB's ticker is CALT and the CUSIP is 13124Q106. A total of 16 filers reported holding CALLIDITAS THERAPEUTICS AB in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,805 | +176.7% | 756 | +140.0% | 0.00% | – |
Q2 2023 | $4,989 | -29.7% | 315 | +6.4% | 0.00% | – |
Q1 2023 | $7,095 | +100.7% | 296 | +42.3% | 0.00% | – |
Q4 2022 | $3,536 | -11.6% | 208 | -2.3% | 0.00% | – |
Q2 2022 | $4,000 | -75.0% | 213 | -73.4% | 0.00% | – |
Q1 2022 | $16,000 | -50.0% | 802 | -38.3% | 0.00% | – |
Q4 2021 | $32,000 | +700.0% | 1,300 | +573.6% | 0.00% | – |
Q3 2021 | $4,000 | – | 193 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 750,000 | $13,695,000 | 0.37% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 26,688 | $487,323 | 0.30% |
SPHERA FUNDS MANAGEMENT LTD. | 11,863 | $216,618 | 0.04% |
Nalls Sherbakoff Group, LLC | 35 | $640 | 0.00% |
DEUTSCHE BANK AG\ | 90,550 | $1,653,443 | 0.00% |
Citadel Advisors | 2,700 | $49,302 | 0.00% |
Citadel Advisors | 5,500 | $100,430 | 0.00% |
Citadel Advisors | 4,958 | $90,533 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 22,100 | $403,546 | 0.00% |
SIMPLEX TRADING, LLC | 536 | $9 | 0.00% |